Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,203,925,277
+$457,018,946 QoQ
Shares Held
4,784,316
+39.3% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#41
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. ABBV ranks #1 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,203,925,277 | 4,784,316 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $746,906,331 | 3,434,210 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $776,916,494 | 3,400,221 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $883,113,934 | 3,814,088 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $919,338,364 | 4,952,798 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,329,466,416 | 6,345,296 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,010,663,773 | 5,687,472 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $826,176,734 | 4,183,597 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $718,030,229 | 4,186,277 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $213,701,997 | 1,173,542 | Shares | Defined | 2024-05-28 | |
| 2023-12-31 | $186,400,085 | 1,202,814 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $193,276,412 | 1,296,635 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $181,199,184 | 1,344,906 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $470,484,621 | 2,952,153 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $819,169,897 | 5,068,807 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $825,401,429 | 6,150,074 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $915,279,869 | 5,975,972 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $879,721,200 | 5,426,693 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $736,516,286 | 5,439,559 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $545,855,530 | 5,060,309 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $503,591,247 | 4,470,803 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $357,355,316 | 3,302,119 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $308,781,011 | 2,881,764 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $12,236,410 | 139,701 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,887,094 | 161,816 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,096,051 | 211,262 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||